CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Nuberol Fortedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06628466
NCT06628466N/ACompleted

Clinical Response of Nuberol Forte in Chronic Neck Pain in Routine Rehabilitation Centers

The Searle Company Limited Pakistan·observational·Posted Oct 8, 2024·Updated Oct 8, 2024

In Brief

An observational study evaluating Nuberol Forte for Chronic Neck Pain. Completed, enrolled 150 participants across 1 site.

Detailed Summary

Globally, the prevalence of neck pain ranges from 16.7% to 75.1%. Despite conducting multiple studies on specific subject pools in Pakistan, primarily focusing on professional-related neck pain, there is a lack of accurate data to determine the local prevalence of neck pain or the effective management of neck pain through physical therapy and pharmacological intervention. The purpose of this study is to evaluate the clinical effectiveness of paracetamol and orphenadrine (Nuberol Forte) when combined with physical therapy in Pakistani patients suffering from neck pain at regular rehabilitation centers.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesPakistan
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedOct 8, 2024
Enrollment StartNov 25, 2022
Primary CompletionDec 20, 2023
Study CompletionJan 15, 2024
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 1.7 years ago

Interventions

Nuberol Fortedrug

Quality of Life study